Shoulder Innovations, Inc. (SI)
NYSE: SI · Real-Time Price · USD
15.20
+0.08 (0.53%)
Dec 5, 2025, 4:00 PM EST - Market closed
Shoulder Innovations Market Cap
Shoulder Innovations has a market cap or net worth of $313.15 million as of December 5, 2025.
Market Cap
313.15M
Enterprise Value
190.84M
1-Year Change
n/a
Ranking
Category
Stock Price
$15.20
Market Cap Chart
Since the IPO on July 31, 2025, Shoulder Innovations's market cap has increased from $298.85M to $313.15M, an increase of 4.78%. That is a compound annual growth rate of 14.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 313.15M | 0.53% |
| Dec 4, 2025 | 311.50M | -0.72% |
| Dec 3, 2025 | 313.76M | 0.07% |
| Dec 2, 2025 | 313.56M | 5.11% |
| Dec 1, 2025 | 298.31M | -6.22% |
| Nov 28, 2025 | 318.09M | -3.98% |
| Nov 26, 2025 | 331.28M | 6.84% |
| Nov 25, 2025 | 310.06M | 0.53% |
| Nov 24, 2025 | 308.41M | 1.91% |
| Nov 21, 2025 | 302.64M | 6.14% |
| Nov 20, 2025 | 285.13M | -2.12% |
| Nov 19, 2025 | 291.31M | -4.78% |
| Nov 18, 2025 | 305.94M | 2.63% |
| Nov 17, 2025 | 298.11M | -1.56% |
| Nov 14, 2025 | 302.84M | - |
| Nov 13, 2025 | 302.84M | -2.00% |
| Nov 12, 2025 | 309.03M | 32.15% |
| Nov 11, 2025 | 233.84M | 4.32% |
| Nov 10, 2025 | 224.16M | -0.36% |
| Nov 7, 2025 | 224.98M | -1.52% |
| Nov 6, 2025 | 228.44M | -0.62% |
| Nov 5, 2025 | 229.86M | 1.07% |
| Nov 4, 2025 | 227.42M | -0.98% |
| Nov 3, 2025 | 229.66M | -3.75% |
| Oct 31, 2025 | 238.62M | -1.51% |
| Oct 30, 2025 | 242.28M | 1.54% |
| Oct 29, 2025 | 238.62M | -3.14% |
| Oct 28, 2025 | 246.36M | -1.71% |
| Oct 27, 2025 | 250.63M | 0.08% |
| Oct 24, 2025 | 250.43M | -2.07% |
| Oct 23, 2025 | 255.72M | -2.18% |
| Oct 22, 2025 | 261.42M | 3.80% |
| Oct 21, 2025 | 251.85M | -1.36% |
| Oct 20, 2025 | 255.31M | 0.32% |
| Oct 17, 2025 | 254.50M | 1.63% |
| Oct 16, 2025 | 250.43M | 1.57% |
| Oct 15, 2025 | 246.56M | -2.96% |
| Oct 14, 2025 | 254.09M | 2.63% |
| Oct 13, 2025 | 247.58M | -1.86% |
| Oct 10, 2025 | 252.26M | -5.78% |
| Oct 9, 2025 | 267.73M | 1.08% |
| Oct 8, 2025 | 264.88M | -0.69% |
| Oct 7, 2025 | 266.72M | 0.15% |
| Oct 6, 2025 | 266.31M | 7.30% |
| Oct 3, 2025 | 248.19M | 1.50% |
| Oct 2, 2025 | 244.52M | -0.08% |
| Oct 1, 2025 | 244.73M | -4.22% |
| Sep 30, 2025 | 255.52M | -0.08% |
| Sep 29, 2025 | 255.72M | 3.80% |
| Sep 26, 2025 | 246.36M | -3.20% |
| Sep 25, 2025 | 254.50M | -3.03% |
| Sep 24, 2025 | 262.44M | -3.66% |
| Sep 23, 2025 | 272.42M | -4.97% |
| Sep 22, 2025 | 286.67M | -2.36% |
| Sep 19, 2025 | 293.59M | -1.50% |
| Sep 18, 2025 | 298.07M | -1.35% |
| Sep 17, 2025 | 302.14M | -5.48% |
| Sep 16, 2025 | 319.65M | 5.09% |
| Sep 15, 2025 | 304.18M | -4.90% |
| Sep 12, 2025 | 319.85M | 4.73% |
| Sep 11, 2025 | 305.40M | 17.74% |
| Sep 10, 2025 | 259.39M | -14.95% |
| Sep 9, 2025 | 304.99M | -3.72% |
| Sep 8, 2025 | 316.78M | 7.07% |
| Sep 5, 2025 | 295.86M | -2.69% |
| Sep 4, 2025 | 304.03M | 1.46% |
| Sep 3, 2025 | 299.65M | -6.12% |
| Sep 2, 2025 | 319.17M | 8.10% |
| Aug 29, 2025 | 295.27M | 0.07% |
| Aug 28, 2025 | 295.07M | -6.09% |
| Aug 27, 2025 | 314.19M | 5.63% |
| Aug 26, 2025 | 297.46M | -0.60% |
| Aug 25, 2025 | 299.25M | 18.17% |
| Aug 22, 2025 | 253.23M | 4.18% |
| Aug 21, 2025 | 243.07M | 0.83% |
| Aug 20, 2025 | 241.07M | -2.73% |
| Aug 19, 2025 | 247.85M | -13.19% |
| Aug 18, 2025 | 285.50M | 1.70% |
| Aug 15, 2025 | 280.72M | 2.40% |
| Aug 14, 2025 | 274.15M | 4.72% |
| Aug 13, 2025 | 261.79M | -0.08% |
| Aug 12, 2025 | 261.99M | 8.23% |
| Aug 11, 2025 | 242.07M | -2.10% |
| Aug 8, 2025 | 247.25M | 2.06% |
| Aug 7, 2025 | 242.27M | -6.89% |
| Aug 6, 2025 | 260.20M | -7.77% |
| Aug 5, 2025 | 282.12M | -0.77% |
| Aug 4, 2025 | 284.31M | 0.14% |
| Aug 1, 2025 | 283.91M | -5.00% |
| Jul 31, 2025 | 298.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.27B |
| Johnson & Johnson | 487.23B |
| AbbVie | 400.84B |
| UnitedHealth Group | 299.88B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 248.80B |
| Abbott Laboratories | 218.05B |